$2.3B USDA fund aims to elevate U.S. Agri exports

Oct 27, 2023

The agricultural community is buzzing with the U.S. Department of Agriculture's (USDA) recent announcement. A generous fund of $2.3 billion from the Commodity Credit Corporation will be directed towards advancing the global reach of U.S. agricultural products and extending international food aid.

Of this amount, the USDA plans to invest $1.3 billion in the Regional Agricultural Trade Promotion Program, with the remaining $1 billion being funneled towards international food aid.

Jim Mulhern, at the helm of the National Milk Producers Federation (NMPF), lauds this step. With the U.S. dairy sector's deep reliance on exports, this new injection of funds is anticipated to intensify its global competitive edge. Mulhern also expressed hope that Congress will further fund vital programs like the Market Access Program and the Foreign Market Development Program.

Interestingly, these two programs have not seen a budget hike in over a decade and a half, despite their evident profitability. This has prompted calls from the likes of USDEC and NMPF for increased funding.

Ending on a positive note, Krysta Harden, leading the U.S. Dairy Export Council (USDEC), conveyed her optimism about the future of the dairy supply chain, reiterating the importance of trade opportunities. With backing from influential Senators and USDA's latest move, the path to broader markets and enriched dairy promotions in food aid appears promising.

Source : wisconsinagconnection

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.